Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1426.80
-11.95 (-0.83%) Cipla informs about disclosure
Date: 27-07-2022Cipla has informed that lnvaGen Pharmaceuticals Inc., wholly owned step-down subsidiary of the Company in USA has entered into a Share Repurchase Agreement for sale of equity stake held in Avenue Therapeutics, Inc.
The above information is a part of company’s filings submitted to BSE.